Literature DB >> 22805763

[Pain as adverse drug reaction].

Birgit Böhmdorfer1, Daniel Schaffarzick, Marietta Nagano, Susanne Melitta Janowitz, Ekkehard Schweitzer.   

Abstract

We present a multidisciplinary (anaesthesiology--clinical pharmacy--bioinformatics) analysis of pain as possible adverse drug reaction taking different manifestations of pain, indication groups, relevance to the Austrian drug market and possible mechanistic influence of drugs on development and apprehension of pain into consideration.We designed an overview that shows how transmitters that play a part in nociception and antinociception can be influenced by drugs. This allows conclusions to the dolorigene potential of therapeutics.

Entities:  

Mesh：

Year:  2012        PMID： 22805763     DOI： 10.1007/s10354-012-0132-x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  10 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  A method for assessing drug therapy appropriateness.

Authors:  J T Hanlon; K E Schmader; G P Samsa; M Weinberger; K M Uttech; I K Lewis; H J Cohen; J R Feussner
Journal:  J Clin Epidemiol       Date:  1992-10       Impact factor: 6.437

3.  Adverse drug responses: An increasing threat to the well-being of older patients: Comment on "Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older".

Authors:  Edward L Schneider; Vito M Campese
Journal:  Arch Intern Med       Date:  2010-07-12

4.  Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score.

Authors:  Graziano Onder; Mirko Petrovic; Balamurugan Tangiisuran; Marieke C Meinardi; Winih P Markito-Notenboom; Annemie Somers; Chakravarthi Rajkumar; Roberto Bernabei; Tischa J M van der Cammen
Journal:  Arch Intern Med       Date:  2010-07-12

5.  Statin-associated muscle-related adverse effects: a case series of 354 patients.

Authors:  Stephanie Cham; Marcella A Evans; Julie O Denenberg; Beatrice A Golomb
Journal:  Pharmacotherapy       Date:  2010-06       Impact factor: 4.705

Review 6.  Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Authors:  A Blenkinsopp; P Wilkie; M Wang; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

7.  Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT(3) receptor-mediated effect.

Authors:  F Libert; J Bonnefont; E Bourinet; E Doucet; A Alloui; M Hamon; J Nargeot; A Eschalier
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

8.  Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria.

Authors:  Jochen Schuler; Christina Dückelmann; Wolfgang Beindl; Erika Prinz; Thomas Michalski; Max Pichler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

9.  Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

Authors:  Beatrice A Golomb; John J McGraw; Marcella A Evans; Joel E Dimsdale
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

10.  Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine.

Authors:  Wen Hua Xiao; Gary J Bennett
Journal:  Pain       Date:  2007-07-30       Impact factor: 7.926
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.